Usana Health Sciences earnings were $8.9M for the trailing 12 months ending Apr 4, 2026, with -73.8% growth year over year. The latest USNA earnings report on Apr 4, 2026 announced Q2 2026 earnings of $7.5M, down 523.4% from last quarter. For the last reported fiscal year 2026 ending Jan 3, 2026, USNA reported annual earnings of $10.8M, with -74.4% growth.
USNA past earnings growth
How has USNA's earnings growth performed historically?
Usana Health Sciences Earnings Reports & History FAQ
What were Usana Health Sciences's earnings last quarter?
On USNA's earnings call on Invalid Date, Usana Health Sciences (NYSE: USNA) reported Q1 2026 earnings per share (EPS) of $0.41, up 16.33% year over year. Total USNA earnings for the quarter were $7.52 million. In the same quarter last year, Usana Health Sciences's earnings per share (EPS) was $0.49.
Is Usana Health Sciences profitable or losing money?
As of the last Usana Health Sciences earnings report, Usana Health Sciences is currently profitable. Usana Health Sciences's net profit (also called net income) for the twelve months ending Apr 4, 2026 was $8.87 million, a 74.57% decrease year over year.
What was USNA's earnings growth in the past year?
As of Usana Health Sciences's earnings date in Invalid Date, Usana Health Sciences's earnings has grown -73.77% year over year. This is 92.25 percentage points lower than the US Packaged Foods industry earnings growth rate of 18.48%. USNA earnings in the past year totalled $8.87 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.